Note: Ingredients listed on restricted chemical lists
EC/CAS
200-661-7/67-63-0
Name of the chemical
Propan-2-ol
Concentration
20 - 50
EC/CAS
200-579-1/64-18-6
Name of the chemical
Formic acid
Concentration
<4
General Information
Version
1.1
Revision date
2023-10-26
Product name
Rebel BGE
1.2.1 Relevant identified uses
Professional use
1.2.2. Uses advised against
Not for use in diagnostic procedures
Manufacturer Name
908 Devices
Emergency telephone
1 (844) 908 - 4357
Icons in SDS
Company Information
company name
908 Devices
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H315, H319, H336
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Hazard statements
see section 16 : H225 - Highly flammable liquid and vapour. H315 - Causes skin irritation. H319 - Causes serious eye irritation. H336 - May cause drowsiness or dizziness.
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Hazard pictograms
GHS02 GHS07
Signal word
Danger
Contains
Isopropyl alcohol; Formic acid
Precautionary statements
P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P233 - Keep container tightly closed. P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P264 - Wash hands, forearms and face thoroughly after handling. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P403+P235 - Store in a well-ventilated place. Keep cool.
Other hazards which do not result in classification
Exposure may aggravate those with pre-existing eye, skin, or respiratory conditions. Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %